MDWD
MediWound Ltd

1,851
Mkt Cap
$217.86M
Volume
82,317.00
52W High
$22.51
52W Low
$14.14
PE Ratio
-8.09
MDWD Fundamentals
Price
$16.96
Prev Close
$16.97
Open
$17.08
50D MA
$17.47
Beta
0.83
Avg. Volume
82,676.93
EPS (Annual)
-$2.10
P/B
4.99
Rev/Employee
$140,157.02
$165.65
Loading...
Loading...
News
all
press releases
MediWound (NASDAQ:MDWD) Stock Passes Below 200-Day Moving Average - Time to Sell?
MediWound (NASDAQ:MDWD) Shares Pass Below 200-Day Moving Average - Here's Why...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Menora Mivtachim Holdings LTD. Purchases 61,039 Shares of MediWound Ltd. $MDWD
Menora Mivtachim Holdings LTD. increased its position in MediWound Ltd. (NASDAQ:MDWD - Free Report) by 348.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·10d ago
News Placeholder
Rosalind Advisors Inc. Buys 341,993 Shares of MediWound Ltd. $MDWD
Rosalind Advisors Inc. boosted its stake in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) by 84.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·10d ago
News Placeholder
FY2030 Earnings Forecast for MediWound Issued By Maxim Group
MediWound Ltd. (NASDAQ:MDWD - Free Report) - Equities research analysts at Maxim Group decreased their FY2030 earnings per share estimates for MediWound in a note issued to investors on Monday, March...
MarketBeat·10d ago
News Placeholder
MediWound (NASDAQ:MDWD) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of MediWound from a "hold" rating to a "strong sell" rating in a research report on Saturday...
MarketBeat·16d ago
News Placeholder
MediWound Q4 Earnings Call Highlights
MediWound (NASDAQ:MDWD) executives said 2025 marked a pivotal year for the company, highlighting progress in its late-stage EscharEx chronic wound program and the completion of an expanded...
MarketBeat·17d ago
News Placeholder
MediWound (NASDAQ:MDWD) Releases Quarterly Earnings Results
MediWound (NASDAQ:MDWD - Get Free Report) released its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.56) EPS for the quarter, topping the consensus estimate of...
MarketBeat·17d ago
News Placeholder
MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of +14.07% and -10.76%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
News Placeholder
What to Expect from MediWound's Earnings
read more...
Benzinga·18d ago
News Placeholder
MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference
MediWound (NASDAQ:MDWD) CEO Ofer Gonen provided an update on the company's commercial burn franchise, late-stage chronic wound program, manufacturing expansion plans, and government-related efforts...
MarketBeat·22d ago
<
1
2
...
>

Latest MDWD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.